about
Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology GuidelineSurgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancersPractice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus StatementDevelopment and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K).Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.Two dermoid cysts developing in an accessory ovary and an eutopic ovarySurvival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.Development and evaluation of Korean version of Quality of Sexual Function (QSF-K) in healthy Korean womenHereditary portion as an initial genetic approach in gynecologic cancer: synchronous tumor of ovary and endometrium.The Korean guideline for cervical cancer screeningAssessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in KoreaIncidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer.Endometrioid adenocarcinoma in urethrovaginal septum: a diagnostic pitfall.Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective studyRole of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.In reply: Different role of secondary cytoreductive surgery by surgeon's experience and hospital facility.Computed tomography-based quantitative assessment of lower extremity lymphedema following treatment for gynecologic cancer.Development of the short version of the Gynecologic Cancer Lymphedema Questionnaire: GCLQ-7.Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies.Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix.Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.Role and clinical application of next-generation sequencing (NGS) for ovarian cancer.The Author's Response: Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma.Hereditary non-polyposis colorectal cancer/Lynch syndrome in Korean patients with endometrial cancer.Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma.Application of a subcutaneous negative pressure drain without subcutaneous suture: impact on wound healing in gynecologic surgery.Ovarian clear cell carcinoma: high risk of venous thromboembolism.Learning curve analysis of laparoscopic radical hysterectomy and lymph node dissection in early cervical cancer.Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study.Metastasis at the site of a venous needle puncture in a patient with advanced cervical cancer.Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study.Unusual 2-[18F]-fluoro-2-deoxy-D-glucose accumulation induced by postoperative intestinocutaneous fistula in the patient with uterine cervical cancer and SLE.
P50
Q24337272-D12F75FA-BFA9-4299-A790-CFF413D9DA0BQ26749285-189AA604-6436-4B6A-9F47-5E4370AFF55DQ28069868-1C786EBF-3305-455D-BB14-FE95E467559AQ29994662-E7EBA495-65CE-4612-A7A8-AA406DE5D2C7Q30355066-B68A0400-8D01-40BD-B80F-91F21436B934Q33398670-AFEA1C06-26D6-4903-8991-9466C680952AQ33631658-B9BFB3A8-3CE2-4FAC-9BAB-675E03807341Q33735142-D76DB8DA-9C18-47A7-B0AF-0C4B9DA25FD9Q33749147-D43504CC-0C1B-4D13-AAA1-9F9ADBC33BF8Q35758731-52546376-1394-4BF7-94E6-35D4A5510E01Q35876962-4ABFBF40-5B1E-4BE1-833E-80804FECED87Q36241717-2B2B754B-08B1-457D-8FFC-D9985FCD4F12Q36313275-F9260584-A9A4-41CB-892F-9B2D1F55BD85Q36415295-A90EF2AF-5D1C-45B1-999F-E2DA08369476Q36893991-A4D3B5D6-6FC4-4924-B7BB-E94BD51B46D3Q37065182-85786410-5ADA-4FFD-8FCD-8CE5DCA1D612Q37116893-F3BF97D7-5FAA-423C-9769-2A93EA120E0DQ37177643-043DD286-A36A-45FC-B99D-E6FB904C4438Q37248554-A6E00DAC-1404-46CB-A703-B6D1D07EA342Q37249280-B6DCBD2F-AA41-4CEE-8742-5233DE2FA5CBQ37326018-87C6C2A1-950F-40DC-8A04-E319C2523B56Q37376660-47647097-CF75-4E26-B4BF-CDC01DBA0BA5Q37662467-93B77E20-2D8E-4D94-A11D-503ECBF32666Q37662479-AC193808-55B3-440B-8EC6-905A846FADDBQ37762683-BBEEC67E-CE48-40A9-860C-97E3A9C40508Q37938363-DC85E5CB-C573-4EF3-B3FC-82793DF1340BQ38494130-E0F459FB-818E-4B5B-A155-5F5D73160362Q40461704-EA0ACD91-6022-449A-9F24-166122B165BAQ42345758-4B100260-C503-4048-AF47-946D6ADA4E0BQ42931309-FDF119EF-E787-4418-88D9-7F1BA79710EDQ43054485-7841D698-4A6A-4E0A-BB67-CE1B9293E6D9Q43695489-CCA52983-DD0E-46BB-AFDF-F109D1F098DBQ43833160-41310EAC-C562-4EEF-BC73-44EFC8BC6F94Q44214949-60BE1250-EB65-4E09-9FBE-847CD8CAF54AQ45021151-88944F41-6AA8-45BD-93A0-578FA818A743Q45061997-0AA365EC-AD43-45BE-AF59-BA70954F49B9Q45740792-00FB6F23-E073-47D7-8B47-406D44606D52Q46018861-C57E0BD5-7E26-4C8B-823F-8BAA0FF5DF63Q46147063-D47AFA43-7D76-4035-B10C-B0C783522218Q46208225-A3067277-D023-4D72-9851-4F00BFCE79AB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Myong Cheol Lim
@ast
Myong Cheol Lim
@en
Myong Cheol Lim
@es
Myong Cheol Lim
@nl
Myong Cheol Lim
@sl
type
label
Myong Cheol Lim
@ast
Myong Cheol Lim
@en
Myong Cheol Lim
@es
Myong Cheol Lim
@nl
Myong Cheol Lim
@sl
prefLabel
Myong Cheol Lim
@ast
Myong Cheol Lim
@en
Myong Cheol Lim
@es
Myong Cheol Lim
@nl
Myong Cheol Lim
@sl
P106
P1153
25641518400
P21
P31
P496
0000-0001-8964-7158